
NXY-059
CAS No. 168021-79-2
NXY-059( NXY 059 | NXY059 | Disufenton sodium )
Catalog No. M12566 CAS No. 168021-79-2
NXY-059 (Disufenton sodium) is a free radical-trapping agent that demonstrates a considerable neuroprotective effect in vivo.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 33 | In Stock |
![]() ![]() |
10MG | 54 | In Stock |
![]() ![]() |
25MG | 106 | In Stock |
![]() ![]() |
50MG | 195 | In Stock |
![]() ![]() |
100MG | 357 | In Stock |
![]() ![]() |
200MG | 524 | In Stock |
![]() ![]() |
500MG | 822 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameNXY-059
-
NoteResearch use only, not for human use.
-
Brief DescriptionNXY-059 (Disufenton sodium) is a free radical-trapping agent that demonstrates a considerable neuroprotective effect in vivo.
-
DescriptionNXY-059 (Disufenton sodium) is a free radical-trapping agent that demonstrates a considerable neuroprotective effect in vivo; exhibits a substantial protective effect, lessening the disability caused by an experimentally induced stroke in a primate species, shows significantly decreased neurological impairment in rat model of hemorrhagic stroke.Stroke Phase 3 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsNXY 059 | NXY059 | Disufenton sodium
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
IndicationStroke
Chemical Information
-
CAS Number168021-79-2
-
Formula Weight381.3329
-
Molecular FormulaC11H13NNa2O7S2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)(C)[N+](=CC1=C(C=C(C=C1)S(=O)(=O)[O-])S(=O)(=O)[O-])[O-].[Na+].[Na+]
-
Chemical Name1,3-Benzenedisulfonic acid, 4-[[(1,1-dimethylethyl)oxidoimino]methyl]-, sodium salt (1:2)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Marshall JW, et al. Stroke. 2001 Jan;32(1):190-8.
2. Kuroda S, et al. J Cereb Blood Flow Metab. 1999 Jul;19(7):778-87.
3. Peeling J, et al. Neuropharmacology. 2001 Mar;40(3):433-9.
4. Sydserff SG, et al. Br J Pharmacol. 2002 Jan;135(1):103-12.
molnova catalog



related products
-
Lapathoside A
Lapathoside A and vanicoside B, inhibited the promotion stages on two-stage carcinogenesis induced by TPA.
-
EAAT2 activator 1
F2005-0304 is a thiopyridazine derivative that has been found to increase EAAT2 protein levels in astrocytes.
-
Nerol
Nerol is a monoterpene found in many essential oils such as lemon balm and hop.Nerol can lessened the severity of ouabain-triggered arrhythmias in mammalian heart.